Research Articles Abstract - 2010 Issues Archive

[Giuseppe]

Research Articles Abstracts - July 16 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - July 16 2010 Issue

1. Saha RK, Takahashi T, Kurebayashi Y, Fukushima K, et al.
   • Antiviral effect of strictinin on influenza virus replication.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Zarocostas J.
   • WHO swine flu review committee promises to probe links with drug industry.
   • BMJ. 2010;341:c3648.
   • PubMed
3. Du L, Zhao G, Zhang X, Liu Z, et al.
   • Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies.
   • Biochem Biophys Res Commun. 2010;397:580-5.
   • PubMed
   • Abstract available
4. Boltz DA, Aldridge JR Jr, Webster RG, Govorkova EA, et al.
   • Drugs in development for influenza.
   • Drugs. 2010;70:1349-62.
   • PubMed
   • Abstract available
5. Song MS, Lee JH, Pascua PN, Baek YH, et al.
   • Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
6. Wenzel JJ, Panning M, Kaul KL, Mangold KA, et al.
   • Analytical Performance Determination and Clinical Validation of the Novel Roche RealTime ready Influenza A/H1N1 Detection Set.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
7. Jiang WM, Liu S, Chen J, Hou GY, et al.
   • Molecular epidemiological surveys of H5 subtype highly pathogenic avian influenza viruses in poultry in China in 2007-2009.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
8. Widjaja I, de Vries E, Tscherne DM, Garcia-Sastre A, et al.
   • Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a post-fusion step.
   • J Virol. 2010.
   • PubMed
   • Abstract available
9. Hurt AC, Nor'e SS, McCaw JM, Fryer HR, et al.
   • Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets using a competitive mixtures model.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Moncorge O, Mura M, Barclay WS.
    • Evidence for avian and human host cell factors that affect the activity of influenza polymerase.
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Bertram S, Glowacka I, Blazejewska P, Soilleux E, et al.
    • TMPRSS2 and TMPRSS4 facilitate trypsin-independent influenza virus spread in Caco-2 cells.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Negovetich NJ, Webster RG.
    • Thermostability of subpopulations of H2N3 influenza isolates from Mallard ducks.
    • J Virol. 2010.
    • PubMed
    • Abstract available
13. Gras S, Kedzierski L, Valkenburg SA, Laurie K, et al.
    • Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
    • Proc Natl Acad Sci U S A. 2010;107:12599-604.
    • PubMed
    • Abstract available
14. Bommakanti G, Citron MP, Hepler RW, Callahan C, et al.
    • Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
15. Grandea AG 3rd, Olsen OA, Cox TC, Renshaw M, et al.
    • Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses.
    • Proc Natl Acad Sci U S A. 2010;107:12658-63.
    • PubMed
    • Abstract available
16. Gravel C, Li C, Wang J, Hashem AM, et al.
    • Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
17. Lee BY, Bailey RR, Wiringa AE, Afriyie A, et al.
    • Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Venkat A, Chan-Tompkins NH, Hegde GG, Chuirazzi DM, et al.
    • Feasibility of integrating a clinical decision support tool into an existing computerized physician order entry system to increase seasonal influenza vaccination in the emergency department.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
19. Moules V, Ferraris O, Terrier O, Giudice E, et al.
    • In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: Toward a new mechanism of viral resistance?
    • Virology. 2010.
    • PubMed
    • Abstract available
20. Watanabe R, Lamb RA.
    • Influenza virus budding does not require a functional AAA+ ATPase, VPS4.
    • Virus Res. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - July 22 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - July 22 2010 Issue

1. Sundararajan A, Ganapathy R, Huan L, Dunlap JR, et al.
   • Influenza virus variation in susceptibility to inactivation by pomegranate polyphenols is determined by envelope glycoproteins.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Smee DF, Hurst BL, Wong MH, Tarbet EB, et al.
   • Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
3. Mueller SN, Langley WA, Li G, Garcia-Sastre A, et al.
   • Qualitatively Different Memory CD8+ T Cells Are Generated after Lymphocytic Choriomeningitis Virus and Influenza Virus Infections.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
4. Limper M, Smit PM, Bongers KM, van Zanten AP, et al.
   • Procalcitonin in children with suspected Novel Influenza A (H1N1) infection.
   • J Infect. 2010.
   • PubMed
5. Wu J, Li W, Wang HQ, Chen JT, et al.
   • A Rapid Immune Response to 2009 Influenza A(H1N1) Vaccines in Adults: A Randomized, Double-Blind, Controlled Trial.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
6. Wu J, Liu SZ, Dong SS, Dong XP, et al.
   • Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I-II randomized trial.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
7. Lin CJ, Nowalk MP, Toback SL, Rousculp MD, et al.
   • Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
8. Petersson P, Hedenskog M, Alves D, Brytting M, et al.
   • The Eurocine((R)) L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
9. Dedoukou X, Nikolopoulos G, Maragos A, Giannoulidou S, et al.
   • Attitudes towards vaccination against seasonal influenza of health-care workers in primary health-care settings in Greece.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
10. Reemers SS, Jansen C, Koerkamp MJ, van Haarlem D, et al.
    • Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: A transcriptomics analysis of adjuvanted vaccines.
    • Vaccine. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - July 31 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - July 31 2010 Issue

1. ...
   • Influenza vaccination of children and adolescents decreased influenza infection in nonvaccinated community members.
   • Ann Intern Med. 2010;153:JC110.
   • PubMed
2. Casalegno JS, Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al.
   • Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.
   • Antiviral Res. 2010;87:242-8.
   • PubMed
   • Abstract available
3. Yoo JK, Baker DP, Fish EN.
   • Interferon-beta modulates type 1 immunity during influenza virus infection.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
4. Guo L, Zheng M, Ding Y, Li D, et al.
   • Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
5. Operario DJ, Moser MJ, St George K.
   • Highly Sensitive and Quantitative Detection of the H274Y Oseltamivir Resistance Mutation in Seasonal A/H1N1 Influenza.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
6. Lines JL, Hoskins S, Hollifield M, Cauley LS, et al.
   • The Migration of T Cells in Response to Influenza Virus Is Altered in Neonatal Mice.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
7. Tsatsanis C, Margioris AN, Kontoyiannis DP.
   • Association between H1N1 infection severity and obesity-adiponectin as a potential etiologic factor.
   • J Infect Dis. 2010;202:459-60.
   • PubMed
8. Bulach D, Halpin R, Spiro D, Pomeroy L, et al.
   • Molecular analysis of H7 avian influenza viruses from Australia and New Zealand: Genetic diversity and relationships - 1976 to 2007.
   • J Virol. 2010.
   • PubMed
   • Abstract available
9. Chen CJ, Chen GW, Wang CH, Huang CH, et al.
   • Differential localization and function of PB1-F2 derived from different strains of influenza A virus.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Stoner TD, Krauss S, Dubois RM, Negovetich NJ, et al.
    • Antiviral Susceptibility of Avian and Swine Influenza of the N1 Neuraminidase Subtype.
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Trento A, Casas I, Calderon A, Garcia-Garcia ML, et al.
    • Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene.
    • J Virol. 2010;84:7500-12.
    • PubMed
    • Abstract available
12. Gern JE.
    • The ABCs of rhinoviruses, wheezing, and asthma.
    • J Virol. 2010;84:7418-26.
    • PubMed
    • Abstract available
13. Cheung TK, Chin AW, Chan KH, Schumaker M, et al.
    • Evaluation of novel H1N1-specific primer-probe sets using commercial RT-PCR mixtures and a premixed reaction stored in a lyophilized format.
    • J Virol Methods. 2010;165:302-4.
    • PubMed
    • Abstract available
14. Eckert DM, Kay MS.
    • Stalking influenza.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
15. Rosenberg MR, Casarotto MG.
    • Coexistence of two adamantane binding sites in the influenza A M2 ion channel.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
16. Girard MP, Katz J, Pervikov Y, Palkonyay L, et al.
    • Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
17. Jimenez-Garcia R, Hernandez-Barrera V, de Andres AL, Jimenez-Trujillo I, et al.
    • Gender influence in influenza vaccine uptake in Spain: Time trends analysis (1995-2006).
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Kao TM, Hsieh SM, Kung HC, Lee YC, et al.
    • Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
19. Opstelten W, van Essen GA, Heijnen ML, Ballieux MJ, et al.
    • High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
20. Langley WA, Li ZN, Bradley KC, Talekar GR, et al.
    • The effects of preexisting immunity to influenza on responses to influenza vectors in mice.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
21. Foty RG, Guttmann A, Kwong JC, Maaten S, et al.
    • Predictors of universal influenza vaccination uptake in grades 1 and 2 Toronto school children: Effective vaccination strategies should not end with at risk children.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
22. Lapphra K, Dobson S, Bettinger J.
    • Acceptability of Internet adverse event self-reporting for pandemic and seasonal influenza immunization among health care workers.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
23. Rodriguez-Rieiro C, Dominguez-Berjon MF, Esteban-Vasallo MD, Sanchez-Perruca L, et al.
    • Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: Analysis of population registries in primary care in Madrid (Spain).
    • Vaccine. 2010.
    • PubMed
    • Abstract available
24. Shahid Z, Kleppinger A, Gentleman B, Falsey AR, et al.
    • Clinical and immunologic predictors of influenza illness among vaccinated older adults.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
25. Kim S, Jang JE, Yu JR, Chang J, et al.
    • Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
26. Lau YF, Tang LH, Ooi EE, Subbarao K, et al.
    • Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice.
    • Virology. 2010.
    • PubMed
    • Abstract available
27. Cheng X, Xu Q, Song E, Yang CF, et al.
    • The hemagglutinin protein of influenza A/Vietnam/1203/2004 (H5N1) contributes to hyperinduction of proinflammatory cytokines in human epithelial cells.
    • Virology. 2010.
    • PubMed
    • Abstract available
28. Schaap-Nutt A, D'Angelo C, Amaro-Carambot E, Nolan SM, et al.
    • Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.
    • Virology. 2010.
    • PubMed
    • Abstract available
29. Stewart SM, Wu WH, Lalime EN, Pekosz A, et al.
    • The cholesterol recognition/interaction amino acid consensus motif of the influenza A virus M2 protein is not required for virus replication but contributes to virulence.
    • Virology. 2010.
    • PubMed
    • Abstract available
30. Panozzo CA, Stockman LJ, Curns AT, Anderson LJ, et al.
    • Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis.
    • Pediatrics. 2010;126:e116-23.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - August 8 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - August 8 2010 Issue

1. Casalegno JS, Bouscambert-Duchamp M, Caro V, Schuffenecker I, et al.
   • Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Du L, Zhao G, Zhang X, Liu Z, et al.
   • Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies.
   • Biochem Biophys Res Commun. 2010.
   • PubMed
   • Abstract available
3. Dhiman N, Espy MJ, Irish CL, Wright PA, et al.
   • Evidence for Amino Acid Changes in a 57 base-pair Region of Highly Conserved Matrix Gene of Pandemic (H1N1) 2009 Influenza A Virus.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
4. Guervilly C, Coisel Y, Botelho-Nevers E, Dizier S, et al.
   • Significance of high levels of Procalcitonin in patients with Influenza A (H1N1) pneumonia.
   • J Infect. 2010.
   • PubMed
5. Komiya N, Gu Y, Kamiya H, Yahata Y, et al.
   • Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009.
   • J Infect. 2010.
   • PubMed
   • Abstract available
6. Yang P, Deng Y, Pang X, Shi W, et al.
   • Severe, critical and fatal cases of 2009 H1N1 influenza in China.
   • J Infect. 2010.
   • PubMed
   • Abstract available
7. Cowling BJ, Ng DM, Ip DK, Liao Q, et al.
   • Community Psychological and Behavioral Responses through the First Wave of the 2009 Influenza A(H1N1) Pandemic in Hong Kong.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
8. Dao CN, Kamimoto L, Nowell M, Reingold A, et al.
   • Adult Hospitalizations for Laboratory-Positive Influenza during the 2005-2006 through 2007-2008 Seasons in the United States.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
9. Zielecki F, Semmler I, Kalthoff D, Voss D, et al.
   • Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: The role of the C-terminal ESEV motif in the viral NS1 protein.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Octaviani CP, Ozawa M, Yamada S, Goto H, et al.
    • High genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses.
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, et al.
    • Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Jahangir A, Ruenphet S, Hara K, Shoham D, et al.
    • Evaluation of human intestinal epithelial differentiated cells (Caco-2) for replication, plaque formation and isolation of avian influenza viruses.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
13. Mu B, Huang X, Bu P, Zhuang J, et al.
    • Influenza virus detection with pentabody-activated nanoparticles.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
14. Dhumpa R, Bu M, Handberg KJ, Wolff A, et al.
    • Rapid sample preparation for detection and identification of avian influenza virus from chicken faecal samples using magnetic bead microsystem.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
15. ...
    • Regional Influenza A (H1N1) 2009 Monovalent Vaccination Campaign --- Skokie, Illinois, October 16--December 31, 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:909-13.
    • PubMed
    • Abstract available
16. ...
    • Update: influenza activity --- United States, 2009--10 season.
    • MMWR Morb Mortal Wkly Rep. 2010;59:901-8.
    • PubMed
    • Abstract available
17. Pearton M, Kang SM, Song JM, Kim YC, et al.
    • Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Sealy R, Jones BG, Surman SL, Hurwitz JL, et al.
    • Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
19. Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK, et al.
    • Prevalence of high-risk indications for influenza vaccine varies by age, race, and income.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
20. Esposito S, Marchisio P, Ansaldi F, Bianchini S, et al.
    • A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
21. Robach JG, Lamb RA.
    • Analysis of parainfluenza virus-5 hemagglutinin-neuraminidase protein mutants that are blocked in internalization and degradation.
    • Virology. 2010.
    • PubMed
    • Abstract available
22. Sakoda Y, Sugar S, Batchluun D, Erdene-Ochir TO, et al.
    • Characterization of H5N1 highly pathogenic avian influenza virus strains isolated from migratory waterfowl in Mongolia on the way back from the southern Asia to their northern territory.
    • Virology. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - August 14 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - August 14 2010 Issue

1. Grund S, Roggendorf M, Schweiger B.
   • Outbreak of influenza virus A/H1N1 in a hospital ward for immunocompromised patients.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
2. Lopert R, Nolan T.
   • Child influenza vaccination. Panvax febrile reactions not a predictor.
   • BMJ. 2010;341:c3714.
   • PubMed
3. Curran MP, Leroux-Roels I.
   • Inactivated split-virion seasonal influenza vaccine (fluarix(r)): a review of its use in the prevention of seasonal influenza in adults and the elderly.
   • Drugs. 2010;70:1519-43.
   • PubMed
   • Abstract available
4. Sintes X, Nebot M, Izquierdo C, Ruiz L, et al.
   • Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
5. Ortiz de la Tabla V, Masia M, Antequera P, Martin C, et al.
   • Comparison of Combined Nose-Throat Swabs with Nasopharyngeal Aspirates for Detection of Pandemic Influenza A/H1N1 2009 Virus by Real-time RT-PCR.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
6. O'Leary MF, Chappell JD, Stratton CW, Cronin RM, et al.
   • Complex Febrile Seizures Followed by Complete Recovery in an Infant with High Titer 2009 Pandemic Influenza A (H1N1) Infection.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
7. van Leeuwen M, Williams MM, Koraka P, Simon JH, et al.
   • Human picobirnaviruses identified by molecular screening of diarrhea samples.
   • J Clin Microbiol. 2010;48:1787-94.
   • PubMed
   • Abstract available
8. Lebouder F, Lina B, Rimmelzwaan GF, Riteau B, et al.
   • Plasminogen promotes Influenza A virus replication through an annexin II-dependent pathway in absence of neuraminidase.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
9. Resa-Infante P, Recuero-Checa MA, Zamarreno N, Llorca O, et al.
   • Structural and functional characterisation of an influenza virus RNA polymerase-genomic RNA complex.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Coombs KM, Berard A, Xu W, Krokhin O, et al.
    • Quantitative Proteomic Analyses of Influenza virus-Infected Cultured Human Lung Cells.
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Ping J, Dankar SK, Forbes NE, Keleta L, et al.
    • PB2 and HA Mutations are Major Determinants of Host Range and Virulence in Mouse-Adapted Influenza A Virus.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Liu H, Golebiewski L, Dow EC, Krug RM, et al.
    • The ESEV PDZ Binding-Motif of the Avian Influenza A Virus NS1 Protein Protects Infected Cells from Apoptosis through Directly Targeting Scribble.
    • J Virol. 2010.
    • PubMed
    • Abstract available
13. Barry MA.
    • A 29-year-old woman with flu-like symptoms: review of influenza diagnosis and treatment.
    • JAMA. 2010;304:671-8.
    • PubMed
    • Abstract available
14. Mitka M.
    • H1N1 influenza virus reassorting in pigs, poses unknown risk to human health.
    • JAMA. 2010;304:626-7.
    • PubMed
15. ...
    • Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010--11.
    • MMWR Morb Mortal Wkly Rep. 2010;59:989-92.
    • PubMed
    • Abstract available
16. Acharya R, Carnevale V, Fiorin G, Levine BG, et al.
    • Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
17. Heynisch B, Frensing T, Heinze K, Seitz C, et al.
    • Differential activation of host cell signalling pathways through infection with two variants of influenza A/PR/8/34 (H1N1) in MDCK cells.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Ameiss K, Ashraf S, Kong W, Pekosz A, et al.
    • Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
19. Feng L, Mounts AW, Feng Y, Luo Y, et al.
    • Seasonal influenza vaccine supply and target vaccinated population in China, 2004-2009.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
20. Thueng-In K, Maneewatch S, Srimanote P, Songserm T, et al.
    • Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines.
    • Vaccine. 2010.
    • PubMed
    • Abstract available

-
-----

[Giuseppe]

Research Articles Abstracts - August 20 2010 Issue

[Source: US National Library of Medicine (LINK). Edited.]

Research Articles Abstracts - August 20 2010 Issue

1. Sweet M.
   • Australian health authorities' response criticised after adverse events related to influenza vaccination in children.
   • BMJ. 2010;341:c4470.
   • PubMed
2. Girard M.
   • Competing interests. More queries about H1N1 scandal.
   • BMJ. 2010;341:c3716.
   • PubMed
3. Stevenson HL, Loeffelholz MJ.
   • Poor Positive Accuracy of Quickvue Rapid Antigen Tests During the Influenza A (H1N1) 2009 Pandemic.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
4. Kreijtz JH, Suezer Y, Bodewes R, Schwantes A, et al.
   • Evaluation of an MVA-based candidate pandemic influenza A/H1N1 vaccine in the ferret model.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
5. Ong MP, Sam IC, Azwa H, Mohd Zakaria IE, et al.
   • Direct healthcare costs of patients hospitalised with pandemic (h1n1) 2009 influenza in malaysia.
   • J Infect. 2010.
   • PubMed
6. Isais F, Chow A, Lye DC, Llorin R, et al.
   • Pandemic (h1n1) 2009 influenza in hiv-infected adults: clinical features, severity, and outcome.
   • J Infect. 2010.
   • PubMed
7. Laurie KL, Carolan LA, Middleton D, Lowther S, et al.
   • Multiple Infections with Seasonal Influenza A Virus Induce Cross-Protective Immunity against A(H1N1) Pandemic Influenza Virus in a Ferret Model.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
8. Chao DL, Elizabeth Halloran M, Longini IM Jr.
   • School Opening Dates Predict Pandemic Influenza A(H1N1) Outbreaks in the United States.
   • J Infect Dis. 2010;202:877-80.
   • PubMed
   • Abstract available
9. Khatri M, Dwivedi V, Krakowka S, Manickam C, et al.
   • Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Wan Y, Zhou Z, Yang Y, Wang J, et al.
    • Application of an In-Cell Western assay for measurement of influenza A virus replication.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
11. Leiding T, Wang J, Martinsson J, Degrado WF, et al.
    • Proton and cation transport activity of the M2 proton channel from influenza A virus.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
12. Morelon E, Noble CP, Daoud S, Cahen R, et al.
    • Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
13. Masic A, Lu X, Li J, Mutwiri GK, et al.
    • Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
14. Poland GA.
    • Mandating influenza vaccination for health care workers: Putting patients and professional ethics over personal preference.
    • Vaccine. 2010;28:5757-9.
    • PubMed
15. Ramey AM, Pearce JM, Ely CR, Sheffield Guy LM, et al.
    • Transmission and reassortment of avian influenza viruses at the Asian-North American interface.
    • Virology. 2010.
    • PubMed
    • Abstract available
16. Kanai Y, Chittaganpitch M, Nakamura I, Li GM, et al.
    • Distinct propagation efficiencies of H5N1 influenza virus Thai isolates in newly established murine respiratory region-derived cell clones.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
17. Kohno S, Kida H, Mizuguchi M, Shimada J, et al.
    • Efficacy and safety of intravenous peramivir for the treatment of seasonal influenza.
    • Antimicrob Agents Chemother. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - August 28 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - August 28 2010 Issue

1. Dharan NJ, Beekmann SE, Fiore A, Finelli L, et al.
   • Influenza Antiviral Prescribing Practices during the 2007-08 and 2008-09 Influenza Seasons in the Setting of Increased Resistance to Oseltamivir among Circulating Influenza Viruses.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Kmietowicz Z.
   • WHO declares that H1N1 pandemic is officially over.
   • BMJ. 2010;341:c4393.
   • PubMed
3. Renois F, Talmud D, Huguenin A, Moutte L, et al.
   • Rapid Detection of Respiratory Tract Viral infections and Co-infections in Patients with Influenza-like Illnesses by Use of RT-PCR DNA Microarray Systems.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
4. Wang S, Le TQ, Kurihara N, Chida J, et al.
   • Influenza Virus-Cytokine-Protease Cycle in the Pathogenesis of Vascular Hyperpermeability in Severe Influenza.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
5. Marcus PI, Ngunjiri JM, Sekellick MJ, Wang L, et al.
   • In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines.
   • J Virol. 2010.
   • PubMed
   • Abstract available
6. Seibert CW, Kaminski M, Philipp J, Rubbenstroth D, et al.
   • Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.
   • J Virol. 2010.
   • PubMed
   • Abstract available
7. Jewell NA, Cline T, Mertz SE, Smirnov SV, et al.
   • Interferon-{lambda} is the predominant interferon induced by influenza A virus infection in vivo.
   • J Virol. 2010.
   • PubMed
   • Abstract available
8. ...
   • Pandemic influenza--(some) reasons to be cheerful?
   • Lancet. 2010;376:565.
   • PubMed
9. Bryan P, Seabroke S, Davies C.
   • H1N1 vaccine safety: real-time surveillance in the UK.
   • Lancet. 2010;376:417-8.
   • PubMed
10. Zhao G, Du L, Xiao W, Sun S, et al.
    • Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
11. Carlson SJ, Durrheim DN, Dalton CB.
    • Flutracking provides a measure of field influenza vaccine effectiveness, Australia, 2007-2009.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
12. Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, et al.
    • Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
13. Rudolf M, Poppel M, Frohlich A, Breithaupt A, et al.
    • Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
14. Tang XC, Lu HR, Ross TM.
    • Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
15. Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, et al.
    • Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
16. Lee VJ, Tay JK, Chen MI, Phoon MC, et al.
    • Inactivated trivalent seasonal influenza vaccine induces limited cross-reactive neutralizing antibody responses against 2009 pandemic and 1934 PR8 H1N1 strains.
    • Vaccine. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - September 3 2010 Issue

Research Articles Abstracts - September 3 2010 Issue


[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - September 3 2010 Issue

1. Rowe T, Banner D, Farooqui A, Ng DC, et al.
   • In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
   
   
2. Snyder KM.
   • Does hand hygiene reduce influenza transmission?
   • J Infect Dis. 2010;202:1146-7.
   • PubMed
   
   
3. Agrati C, Gioia C, Lalle E, Cimini E, et al.
   • Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course.
   • J Infect Dis. 2010;202:681-9.
   • PubMed
   • Abstract available
   
   
4. ...
   • Estimates of deaths associated with seasonal influenza --- United States, 1976-2007.
   • MMWR Morb Mortal Wkly Rep. 2010;59:1057-62.
   • PubMed
   • Abstract available
   
   
5. Zhang J, While AE, Norman IJ.
   • Knowledge and attitudes regarding influenza vaccination among nurses: A research review.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
   
   
6. Andrews N, Stowe J, Wise L, Miller E, et al.
   • Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
   
   
7. Chu C, Lugovtsev V, Lewis A, Betenbaugh M, et al.
   • Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor.
   • Vaccine. 2010.
   • PubMed
   • Abstract available
   
   
8. Belshe RB.
   • The need for quadrivalent vaccine against seasonal influenza.
   • Vaccine. 2010;28 Suppl 445-53.
   • PubMed
   • Abstract available
   
   
9. Monto AS.
   • Seasonal influenza and vaccination coverage.
   • Vaccine. 2010;28 Suppl 433-44.
   • PubMed
   • Abstract available
   
   
10. Poland GA.
    • The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns.
    • Vaccine. 2010;28 Suppl 43-13.
    • PubMed
    • Abstract available
    
    
11. Falsey AR.
    • New emerging technologies and the intradermal route: the novel way to immunize against influenza.
    • Vaccine. 2010;28 Suppl 424-32.
    • PubMed
    • Abstract available
    
    
12. Monto AS.
    • Seasonal influenza vaccinations: specialized products for different target groups.
    • Vaccine. 2010;28 Suppl 414-23.
    • PubMed
    • Abstract available
    
    
13. Poland GA.
    • Putting the puzzle pieces together: the dynamic landscape of influenza vaccine and policy.
    • Vaccine. 2010;28 Suppl 41-2.
    • PubMed
    
    
14. ...
    • Policy Statement--Recommendations for Prevention and Control of Influenza in Children, 2010-2011.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available
    
    

-
------

[Giuseppe]

Research Articles Abstracts - September 10 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - September 10 2010 Issue

1. Kim Y, Narayanan S, Chang KO.
   • Inhibition of influenza virus replication by plant-derived isoquercetin.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Yavarian J, Azad TM, Zheng X, Gregory V, et al.
   • Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
3. Thitithanyanont A, Engering A, Uiprasertkul M, Ekchariyawat P, et al.
   • Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10.
   • Biochem Biophys Res Commun. 2010;398:752-8.
   • PubMed
   • Abstract available
4. Jannetto PJ, Buchan BW, Vaughan KA, Ledford JS, et al.
   • Real-Time Detection of Influenza A, Influenza B and Respiratory Syncytial Virus A/B in Respiratory Specimens using Nanoparticle Probes.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
5. Han H, Cui ZQ, Wang W, Zhang ZP, et al.
   • New regulatory mechanisms for the intracellular localization and trafficking of influenza A virus NS1 protein revealed by comparative analysis of A/PR/8/34 and A/Sydney/5/97.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
6. Job ER, Deng YM, Tate MD, Bottazzi B, et al.
   • Pandemic H1N1 Influenza A Viruses Are Resistant to the Antiviral Activities of Innate Immune Proteins of the Collectin and Pentraxin Superfamilies.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
7. Adler H.
   • Comment on "Induction of TGF-{beta}1, Not Regulatory T Cells, Impairs Antiviral Immunity in the Lung following Bone Marrow Transplant".
   • J Immunol. 2010;185:1350-1.
   • PubMed
8. Lovato-Salas F, Matienzo-Serment L, Monjaras-Avila C, Godoy-Lozano EE, et al.
   • Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations.
   • J Infect. 2010.
   • PubMed
   • Abstract available
9. McCullers JA, McAuley JL, Browall S, Iverson AR, et al.
   • Influenza Enhances Susceptibility to Natural Acquisition of and Disease Due to Streptococcus pneumoniae in Ferrets.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
10. Li F, Feng L, Pan W, Dong Z, et al.
    • Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in neuraminidase segment.
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Sorrell EM, Song H, Pena L, Perez DR, et al.
    • A 27-Amino Acid Deletion in the NA Stalk Supports Respiratory Replication of an Avian H2N2 Influenza A virus in Chickens.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Liu Y, Childs RA, Matrosovich T, Wharton S, et al.
    • Altered receptor specificity and cell tropism of D222G haemagglutinin mutants from fatal cases of pandemic A(H1N1) 2009 influenza.
    • J Virol. 2010.
    • PubMed
    • Abstract available
13. Belongia EA, Irving SA, Waring SC, Coleman LA, et al.
    • Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections.
    • JAMA. 2010;304:1091-8.
    • PubMed
    • Abstract available
14. Suzuki M, Yoshida LM, Ariyoshi K.
    • Severe pneumonia among Kenyan infants and children.
    • JAMA. 2010;304:964.
    • PubMed
15. Nascimento-Carvalho CM, Ruuskanen O.
    • Severe pneumonia among Kenyan infants and children.
    • JAMA. 2010;304:963.
    • PubMed
16. Kung HC, Huang KC, Kao TM, Lee YC, et al.
    • A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
17. Barriere J, Vanjak D, Kriegel I, Otto J, et al.
    • Acceptance of the 2009 A(H1N1) influenza vaccine among hospital workers in two French cancer centers.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Black S, Della Cioppa G, Malfroot A, Nacci P, et al.
    • Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
19. Kitano M, Itoh Y, Kodama M, Ishigaki H, et al.
    • Establishment of a cynomolgus macaque model of influenza B virus infection.
    • Virology. 2010.
    • PubMed
    • Abstract available
20. Poehling KA, Fairbrother G, Zhu Y, Donauer S, et al.
    • Practice and Child Characteristics Associated With Influenza Vaccine Uptake in Young Children.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available
21. Vesikari T, Karvonen A, Tilman S, Borkowski A, et al.
    • Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine from Infancy to Adolescence.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - September 17 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - September 17 2010 Issue

1. Schoindre Y, Bollee G, Dumont MD, Lesavre P, et al.
   • Cold Agglutinin Syndrome Associated with a 2009 Influenza A H1N1 Infection.
   • Am J Med. 2010.
   • PubMed
2. Minor DS, Eubanks JT, Butler KR Jr, Wofford MR, et al.
   • Improving Influenza Vaccination Rates by Targeting Individuals not Seeking Early Seasonal Vaccination.
   • Am J Med. 2010.
   • PubMed
   • Abstract available
3. Pielak RM, Chou JJ.
   • Solution NMR structure of the V27A drug resistant mutant of influenza A M2 channel.
   • Biochem Biophys Res Commun. 2010.
   • PubMed
   • Abstract available
4. Selvaraju SB, Selvarangan R.
   • Evaluation of Three Influenza A/B Real-time RT-PCR Assays and a New 2009 H1N1 Assay for Detection of Influenza viruses.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
5. Mehta T, McGrath E, Bheemreddy S, Salimnia H, et al.
   • Detection of Oseltamivir Resistance During Therapy of 2009 H1N1 Influenza in Immunocompromised Patients: Utility of Cycle Threshold Values of Qualitative rRT-PCR.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
6. Yoo SJ, Moon SJ, Kuak EY, Yoo HM, et al.
   • Frequent detection of pandemic (H1N1) 2009 virus in stools of hospitalized patients.
   • J Clin Microbiol. 2010;48:2314-5.
   • PubMed
7. Le Goffic R, Bouguyon E, Chevalier C, Vidic J, et al.
   • Influenza A Virus Protein PB1-F2 Exacerbates IFN-{beta} Expression of Human Respiratory Epithelial Cells.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
8. Couch RB, Davis BR.
   • Has Oseltamivir Been Shown to Be Effective for Treatment of H5N1 Influenza?
   • J Infect Dis. 2010.
   • PubMed
9. Adisasmito W, Chan PK, Lee N, Oner AF, et al.
   • Effectiveness of Antiviral Treatment in Human Influenza A(H5N1) Infections: Analysis of a Global Patient Registry.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
10. Keiner B, Maenz B, Wagner R, Cattoli G, et al.
    • Intracellular distribution of NS1 correlates with infectivity and interferon antagonism of an avian influenza virus (H7N1).
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Prabakaran M, He F, Meng T, Madhan S, et al.
    • Neutralizing epitopes of influenza virus hemagglutinin: Target for the development of universal vaccine against H5N1 lineages.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Chutinimitkul S, Herfst S, Steel J, Lowen AC, et al.
    • Virulence-associated substitution D222G in hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding.
    • J Virol. 2010.
    • PubMed
    • Abstract available
13. Brown JN, Palermo RE, Baskin CR, Gritsenko M, et al.
    • Macaque Proteome Response to Highly Pathogenic Avian Influenza and 1918 Reassortant Influenza Virus Infections.
    • J Virol. 2010.
    • PubMed
    • Abstract available
14. Liu WC, Lin SC, Yu YL, Chu CL, et al.
    • Dendritic Cell Activation by Recombinant Hemagglutinin Proteins of H1N1 and H5N1 Influenza A Viruses.
    • J Virol. 2010.
    • PubMed
    • Abstract available
15. Orozovic G, Latorre-Margalef N, Wahlgren J, Muradrasoli S, et al.
    • Degenerate primers for PCR amplification and sequencing of the avian influenza A neuraminidase gene.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
16. Nukiwa N, Suzuki A, Furuse Y, Shimabukuro K, et al.
    • Simplified Screening Method for Detecting Oseltamivir Resistant Pandemic Influenza A (H1N1) 2009 Virus by a RT-PCR-Restriction Fragment Length Polymorphism Assay.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
17. Nazir J, Haumacher R, Abbas MD, Marschang RE, et al.
    • Use of filter carrier technique to measure the persistence of avian influenza viruses in wet environmental conditions.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
18. ...
    • Parental Attitudes and Experiences During School Dismissals Related to 2009 Influenza A (H1N1) --- United States, 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:1131-4.
    • PubMed
    • Abstract available
19. Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, et al.
    • Impact of prior seasonal influenza vaccination and infection on pandemic A(H1N1) influenza virus replication in ferrets.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
20. Uscher-Pines L, Maurer J, Kellerman A, Harris KM, et al.
    • Healthy young and middle age adults: What will it take to vaccinate them for influenza?
    • Vaccine. 2010.
    • PubMed
    • Abstract available
21. Lim SH, Lee JH, Kim BC, Jung SU, et al.
    • Adverse reaction of influenza A (H1N1) 2009 virus vaccination in pregnant women and its effect on newborns.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
22. Baxter R, Ray GT, Fireman BH.
    • Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
23. Surls J, Nazarov-Stoica C, Kehl M, Casares S, et al.
    • Differential effect of CD4(+)Foxp3(+) T-regulatory cells on the B and T helper cell responses to influenza virus vaccination.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
24. ...
    • Policy Statement--Recommendation for Mandatory Influenza Immunization of All Health Care Personnel.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - September 24 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - September 24 2010 Issue

1. Song JM, Kim YC, Barlow PG, Hossain MJ, et al.
   • Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Wang SQ, Cheng XC, Dong WL, Wang RL, et al.
   • Three new powerful Oseltamivir derivatives for inhibiting the neuraminidase of influenza virus.
   • Biochem Biophys Res Commun. 2010.
   • PubMed
   • Abstract available
3. Rossman JS, Jing X, Leser GP, Lamb RA, et al.
   • Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane Scission.
   • Cell. 2010;142:902-13.
   • PubMed
   • Abstract available
4. Gottlinger HG.
   • Influenza Exits the Cell without an ESCRT.
   • Cell. 2010;142:839-41.
   • PubMed
   • Abstract available
5. Deng Y, Pang XH, Yang P, Shi WX, et al.
   • Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
6. Tsukamoto K, Noguchi D, Suzuki K, Shishido M, et al.
   • Broad detection of diverse H5 and H7 hemagglutinin genes of avian influenza viruses by real-time RT-PCR using primer/probe sets containing mixed bases.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
7. Metzgar D, Baynes D, Myers CA, Kammerer P, et al.
   • Initial Identification and Characterization of an Emerging Zoonotic Influenza Virus Prior to Pandemic Spread.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
8. Park KJ, Kwon HI, Song MS, Pascua PN, et al.
   • Rapid evolution of low pathogenic H9N2 avian influenza viruses following poultry vaccination programs.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
9. Vogel AB, Haasbach E, Reiling SJ, Droebner K, et al.
   • Highly Pathogenic Influenza Virus Infection of the Thymus Interferes with T Lymphocyte Development.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
10. Nagarkar DR, Bowman ER, Schneider D, Wang Q, et al.
    • Rhinovirus Infection of Allergen-Sensitized and -Challenged Mice Induces Eotaxin Release from Functionally Polarized Macrophages.
    • J Immunol. 2010.
    • PubMed
    • Abstract available
11. Fulton RB, Meyerholz DK, Varga SM.
    • Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
    • J Immunol. 2010;185:2382-92.
    • PubMed
    • Abstract available
12. Lukacs NW, Smit JJ, Mukherjee S, Morris SB, et al.
    • Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation.
    • J Immunol. 2010;185:2231-9.
    • PubMed
    • Abstract available
13. Zhou H, Zhu J, Tu J, Zou W, et al.
    • Effect on Virulence and Pathogenicity of H5N1 Influenza A Virus through Truncations of NS1 eIF4GI Binding Domain.
    • J Infect Dis. 2010.
    • PubMed
    • Abstract available
14. He Y, Xu K, Keiner B, Zhou J, et al.
    • Influenza A virus replication Induces Cell Cycle Arrest in G0/G1 Phase.
    • J Virol. 2010.
    • PubMed
    • Abstract available
15. Leibowitz JL, Srinivasa R, Williamson ST, Chua MM, et al.
    • GENETIC DETERMINANTS OF MOUSE HEPATITIS VIRUS STRAIN 1 PNEUMOVIRULENCE.
    • J Virol. 2010.
    • PubMed
    • Abstract available
16. Radu GU, Caidi H, Miao C, Tripp RA, et al.
    • Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.
    • J Virol. 2010;84:9632-6.
    • PubMed
    • Abstract available
17. Schuurhof A, Bont L, Pennings JL, Hodemaekers HM, et al.
    • Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.
    • J Virol. 2010;84:9584-94.
    • PubMed
    • Abstract available
18. Pulverer JE, Rand U, Lienenklaus S, Kugel D, et al.
    • Temporal and spatial resolution of type I and III interferon responses in vivo.
    • J Virol. 2010;84:8626-38.
    • PubMed
    • Abstract available
19. Lee DC, Harker JA, Tregoning JS, Atabani SF, et al.
    • CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection.
    • J Virol. 2010;84:8790-8.
    • PubMed
    • Abstract available
20. Hiromoto Y, Uchida Y, Takemae N, Hayashi T, et al.
    • Real-time reverse transcription-PCR assay for differentiating the Pandemic H1N1 influenza virus 2009 from swine influenza viruses.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
21. ...
    • Balamuthia mandrillaris transmitted through organ transplantation --- Mississippi, 2009.
    • MMWR Morb Mortal Wkly Rep. 2010;59:1165-70.
    • PubMed
    • Abstract available
22. Valenciano M, Kissling E, Ciancio BC, Moren A, et al.
    • Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
23. Vellozzi C, Broder KR, Haber P, Guh A, et al.
    • Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the vaccine adverse events reporting system, United States, October 1, 2009-January 31, 2010.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
24. Bugarini R, Casula D, Groth N, Lattanzi M, et al.
    • Associations of the correlates of protection and implication on the statistical power for demonstrating non-inferiority: Application of a re-sampling method on a large phase III influenza vaccine clinical trial.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
25. Brown LE.
    • The role of adjuvants in vaccines for seasonal and pandemic influenza.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
26. Camilloni B, Neri M, Lepri E, Basileo M, et al.
    • An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
27. Ishikawa H, Tanaka K, Kutsukake E, Fukui T, et al.
    • IFN-gamma production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8(+) T cells.
    • Virology. 2010.
    • PubMed
    • Abstract available
28. Lei H, Xu Y, Chen J, Wei X, et al.
    • Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules.
    • Virology. 2010.
    • PubMed
    • Abstract available

-
-----

[Giuseppe]

Research Articles Abstracts - October 1st 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - October 1st 2010 Issue

1. Yang JR, Huang YP, Lin YC, Su CH, et al.
   • Early Findings of Oseltamivir-Resistant Pandemic (H1N1) 2009 Influenza A Viruses in Taiwan.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. McCullers JA, Van De Velde LA, Schultz RD, Mitchell CG, et al.
   • Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
3. Yu H, Liao Q, Yuan Y, Zhou L, et al.
   • Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
   • BMJ. 2010;341:c4779.
   • PubMed
   • Abstract available
4. Horster S, Laubender RP, Lehmeyer L, Ankerst DP, et al.
   • Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals.
   • J Infect. 2010.
   • PubMed
   • Abstract available
5. Lee VJ, Yap J, Cook AR, Chen MI, et al.
   • Effectiveness of Public Health Measures in Mitigating Pandemic Influenza Spread: A Prospective Sero-Epidemiological Cohort Study.
   • J Infect Dis. 2010.
   • PubMed
   • Abstract available
6. McIntyre CL, McWilliam Leitch EC, Savolainen-Kopra C, Hovi T, et al.
   • Analysis of genetic diversity and sites of recombination in human rhinovirus species C.
   • J Virol. 2010;84:10297-310.
   • PubMed
   • Abstract available
7. Agoti CN, Mbisa JL, Bett A, Medley GF, et al.
   • Intrapatient variation of the respiratory syncytial virus attachment protein gene.
   • J Virol. 2010;84:10425-8.
   • PubMed
   • Abstract available
8. Ravid D, Leser GP, Lamb RA.
   • A role for caveolin 1 in assembly and budding of the paramyxovirus parainfluenza virus 5.
   • J Virol. 2010;84:9749-59.
   • PubMed
   • Abstract available
9. Moore C, Telles JN, Corden S, Gao RB, et al.
   • Development and Validation of a Commercial Real-time NASBA Assay for the Rapid Confirmation of Influenza A H5N1 Virus in Clinical Samples.
   • J Virol Methods. 2010.
   • PubMed
   • Abstract available
10. Kumar M.
    • Childhood mortality due to respiratory syncytial virus.
    • Lancet. 2010;376:872.
    • PubMed
11. Schmidt MA, Crane B, Mullooly JP, Naleway AL, et al.
    • Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
12. Puig-Barbera J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, et al.
    • Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
13. Sui Z, Chen Q, Fang F, Zheng M, et al.
    • Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
14. Quach S, Hamid JS, Pereira JA, Heidebrecht CL, et al.
    • Time and motion study to compare electronic and hybrid data collection systems during the pandemic (H1N1) 2009 influenza vaccination campaign.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
15. Wang W, Castelan-Vega JA, Jimenez-Alberto A, Vassell R, et al.
    • A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity.
    • Virology. 2010.
    • PubMed
    • Abstract available
16. Yang JR, Lo J, Ho YL, Wu HS, et al.
    • Pandemic H1N1 and seasonal H3N2 influenza infection in the human population show different distributions of viral loads; which substantially affect the performance of rapid influenza tests.
    • Virus Res. 2010.
    • PubMed
    • Articles Abstract available
17. R Bodewes, Geelhoed-Mieras MM, Nieuwkoop NJ, Hanson JA, et al.
    • Redundancy of the influenza A virus-specific cytotoxic T lymphocyte response in HLA-B*2705 transgenic mice limits the impact of a mutation in the immunodominant NP(383-391) epitope on influenza pathogenesis.
    • Virus Res. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - October 8 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - October 8 2010 Issue

1. Wasilenko JL, Arafa AM, Selim AA, Hassan MK, et al.
   • Pathogenicity of two Egyptian H5N1 highly pathogenic avian influenza viruses in domestic ducks.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
2. Pownall M.
   • Pregnant women to be included in target group for flu vaccination.
   • BMJ. 2010;341:c5432.
   • PubMed
3. Krumkamp R, Kretzschmar M, Rudge JW, Ahmad A, et al.
   • Health service resource needs for pandemic influenza in developing countries: a linked transmission dynamics, interventions and resource demand model.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
4. Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, et al.
   • Pandemic A(H1N1) 2009 influenza: review of the Southern Hemisphere experience.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
5. Gohrbandt S, Veits J, Hundt J, Bogs J, et al.
   • The amino acids adjacent to the hemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
6. Walkiewicz MP, Basu D, Jablonski JJ, Geysen HM, et al.
   • Novel inhibitor of influenza NS1 blocks multi-cycle replication in an RNase L dependent manner.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
7. Li W, Sun W, Liu L, Yang F, et al.
   • IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
8. Richards KA, Topham D, Chaves FA, Sant AJ, et al.
   • Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
9. Thaa B, Herrmann A, Veit M.
   • Intrinsic cytoskeleton-dependent clustering of influenza virus M2 protein with hemagglutinin assessed by FLIM-FRET.
   • J Virol. 2010.
   • PubMed
   • Abstract available
10. Kumar S, Collins PL, Samal SK.
    • "Identification of simian agent 10 as human parainfluenza virus type 3 suggests transmission of a human virus to an African monkey"
    • J Virol. 2010.
    • PubMed
    • Abstract available
11. Kayamuro H, Yoshioka Y, Abe Y, Arita S, et al.
    • Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. van der Vries E, Stelma FF, Boucher CA.
    • Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
    • N Engl J Med. 2010;363:1381-2.
    • PubMed
13. Esposito S, D'Angelo E, Daleno C, Peia F, et al.
    • Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with beta-thalassemia major.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
14. Varella A.
    • Report of the international forum on pandemic influenza 2010 Qingdao, China, 24-25 July 2010.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
15. Smith KJ, Lee BY, Nowalk MP, Raymund M, et al.
    • Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
16. Chen CY, Liu HJ, Tsai CP, Chung CY, et al.
    • Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
17. Rivailler P, Perry IA, Jang Y, Davis CT, et al.
    • Evolution of canine and equine influenza (H3N8) viruses co-circulating between 2005 and 2008.
    • Virology. 2010.
    • PubMed
    • Abstract available
18. Hanley LL, McGivern DR, Teng MN, Djang R, et al.
    • Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation.
    • Virology. 2010;406:241-52.
    • PubMed
    • Abstract available
19. Hu X, Meng W, Dong Z, Pan W, et al.
    • Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice.
    • Virus Res. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - October 15 2010 Issue

[Source: US National Library of Medicine (LINK). Abstracts, edited.]

Research Articles Abstracts - October 15 2010 Issue

1. Goni N, Moratorio G, Ramas V, Coppola L, et al.
   • Phylogenetic analysis of pandemic 2009 influenza A virus circulating in the South American region: genetic relationships and vaccine strain match.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
2. Ginocchio CC, Swierkosz E, McAdam AJ, Marcon M, et al.
   • Multicenter study of clinical performance of the 3M Rapid Detection RSV test.
   • J Clin Microbiol. 2010;48:2337-43.
   • PubMed
   • Abstract available
3. Jackson D, Elderfield RA, Barclay WS.
   • Molecular studies of influenza B virus in the reverse genetics era.
   • J Gen Virol. 2010.
   • PubMed
   • Abstract available
4. Simmonds P, McIntyre C, Savolainen-Kopra C, Tapparel C, et al.
   • Proposals for the classification of human rhinovirus species C into genotypically assigned types.
   • J Gen Virol. 2010;91.
   • PubMed
   • Abstract available
5. Antonis AF, de Jong MC, van der Poel WH, van der Most RG, et al.
   • Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence.
   • J Gen Virol. 2010;91.
   • PubMed
   • Abstract available
6. Steidle S, Martinez-Sobrido L, Mordstein M, Lienenklaus S, et al.
   • Glycine 184 in the non-structural protein NS1 determines virulence of influenza A virus strain PR8 without affecting the host interferon response.
   • J Virol. 2010.
   • PubMed
   • Abstract available
7. Belisle SE, Tisoncik JR, Korth MJ, Carter VS, et al.
   • GENOMIC PROFILING OF TNF-{alpha} RECEPTOR AND IL1 RECEPTOR KNOCKOUT MICE REVEALS A LINK BETWEEN TNF-{alpha} SIGNALING AND INCREASED SEVERITY OF 1918 PANDEMIC INFLUENZA VIRUS INFECTION.
   • J Virol. 2010.
   • PubMed
   • Abstract available
8. van Wielink R, Kant-Eenbergen HC, Harmsen MM, Martens DE, et al.
   • Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
   • J Virol Methods. 2010.
   • PubMed
   • Abstract available
9. Kuehn BM.
   • Mandatory influenza vaccination urged for clinicians, other health workers.
   • JAMA. 2010;304:1545.
   • PubMed
10. ...
    • Influenza activity --- United States and worldwide, June 13-September 25, 2010.
    • MMWR Morb Mortal Wkly Rep. 2010;59:1270-3.
    • PubMed
    • Abstract available
11. ...
    • Seasonal influenza vaccination coverage among children aged 6 months-18 years --- eight immunization information system sentinel sites, United States, 2009-10 influenza season.
    • MMWR Morb Mortal Wkly Rep. 2010;59:1266-9.
    • PubMed
    • Abstract available
12. Yao Q, Fischer KP, Li L, Agrawal B, et al.
    • Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40L) in Pekin ducks.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
13. Thomas RE, Jefferson T, Lasserson TJ.
    • Influenza vaccination for healthcare workers who work with the elderly: Systematic review.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
14. Bone A, Guthmann JP, Nicolau J, Levy-Bruhl D, et al.
    • Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: Results of a national vaccination campaign.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
15. King JC Jr, Lichenstein R, Cummings GE, Magder LS, et al.
    • Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
16. Liao YC, Chen FC, Hsiung CA.
    • Contrasting substitution patterns between HA proteins of avian and human influenza viruses: Implication for monitoring human influenza epidemics.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
17. Legutki JB, Magee DM, Stafford P, Johnston SA, et al.
    • A general method for characterization of humoral immunity induced by a vaccine or infection.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
18. Kuo RL, Zhao C, Malur M, Krug RM, et al.
    • Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-beta transcription.
    • Virology. 2010.
    • PubMed
    • Abstract available
19. Min JY, Chen GL, Santos C, Lamirande EW, et al.
    • Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets.
    • Virology. 2010.
    • PubMed
    • Abstract available

-
------

[Giuseppe]

Research Articles Abstracts - October 22 2010 Issue

[Source: US National Library of Medicine, (LINK). Edited.]

Research Articles Abstracts - October 22 2010 Issue

1. Bantia S, Kellogg D, Parker CD, Babu YS, et al.
   • Combination of Peramivir and Rimantadine Demonstrate Synergistic Antiviral Effects in Sub-lethal Influenza A (H3N2) Virus Mouse Model.
   • Antiviral Res. 2010.
   • PubMed
   • Abstract available
2. Komada H, Kawano M, Uefuji A, Ito M, et al.
   • Completion of the full-length genome sequence of human parainfluenza virus types 4A and 4B: sequence analysis of the large protein genes and gene start, intergenic and end sequences.
   • Arch Virol. 2010.
   • PubMed
   • Abstract available
3. Wise J.
   • GPs face delays in getting flu vaccine.
   • BMJ. 2010;341:c5638.
   • PubMed
4. Zarocostas J.
   • Confusion and delays beset WHO's management of H1N1 pandemic.
   • BMJ. 2010;341:c5534.
   • PubMed
5. Raleigh PJ, Flynn O, O'Connor M, Minihan D, et al.
   • Phylogenetic analysis of H and N2 genes of avian influenza viruses detected in Ireland between 2003 and 2007.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
6. Destefano F, Haber M, Currivan D, Farris T, et al.
   • Factors associated with social contacts in four communities during the 2007-2008 influenza season.
   • Epidemiol Infect. 2010.
   • PubMed
   • Abstract available
7. Miller S, Moayeri M, Wright C, Castro L, et al.
   • Comparison of the GeneXpert(R) FluA PCR to Direct Fluorescent Antibody and Respiratory Viral Panel PCR Assays for Detection of 2009 Novel H1N1 Influenza.
   • J Clin Microbiol. 2010.
   • PubMed
   • Abstract available
8. Wei J, Waithman J, Lata R, Mifsud NA, et al.
   • Influenza A Infection Enhances Cross-Priming of CD8+ T Cells to Cell-Associated Antigens in a TLR7- and Type I IFN-Dependent Fashion.
   • J Immunol. 2010.
   • PubMed
   • Abstract available
9. Kallal LE, Hartigan AJ, Hogaboam CM, Schaller MA, et al.
   • Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology.
   • J Immunol. 2010;185:4137-47.
   • PubMed
   • Abstract available
10. Jackson RJ, Cooper KL, Tappenden P, Rees A, et al.
    • Oseltamivir, Zanamivir And Amantadine In The Prevention Of Influenza: A Systematic Review.
    • J Infect. 2010.
    • PubMed
    • Abstract available
11. Zhou B, Li Y, Halpin R, Hine E, et al.
    • PB2 Residue 158 is a Pathogenic Determinant of Pandemic-H1N1 and H5 Influenza A Viruses in Mice.
    • J Virol. 2010.
    • PubMed
    • Abstract available
12. Lau YF, Santos C, Torres-Velez FJ, Subbarao K, et al.
    • The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines.
    • J Virol. 2010.
    • PubMed
    • Abstract available
13. Pena L, Vincent AL, Ye J, Ciacci-Zanella JR, et al.
    • Modifications in the polymerase genes of a swine-like triple reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    • J Virol. 2010.
    • PubMed
    • Abstract available
14. Zhang J, Li G, Ye X.
    • Cyclin T1/CDK9 interacts with influenza A viral polymerase and facilitates its association with cellular RNA Polymerase II.
    • J Virol. 2010.
    • PubMed
    • Abstract available
15. Antunes I, Kassiotis G.
    • Suppression of Innate Immune Pathology by Regulatory T Cells During Influenza A Virus Infection of Immunodeficient Mice.
    • J Virol. 2010.
    • PubMed
    • Abstract available
16. Seo SU, Kwon HJ, Song JH, Byun YH, et al.
    • MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection.
    • J Virol. 2010.
    • PubMed
    • Abstract available
17. Hong DK, Chang S, Botham CM, Giffon TD, et al.
    • Cationic Lipid/DNA Complex-Adjuvanted Influenza A Vaccination Induces Robust Cross-Protective Immunity.
    • J Virol. 2010.
    • PubMed
    • Abstract available
18. Hayward JJ, Dubovi EJ, Scarlett JM, Janeczko S, et al.
    • Microevolution of canine influenza virus in shelters and its molecular epidemiology in the United States.
    • J Virol. 2010.
    • PubMed
    • Abstract available
19. Varillas D, Bermejo-Martin JF, Almansa R, Rojo S, et al.
    • A new method for detection of pandemic influenza virus using High Resolution Melting analysis of the neuraminidase gene.
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
20. Bennett S, Gunson RN, Maclean A, Miller R, et al.
    • The validation of a real-time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1 (2009).
    • J Virol Methods. 2010.
    • PubMed
    • Abstract available
21. Wang TT, Tan GS, Hai R, Pica N, et al.
    • Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.
    • Proc Natl Acad Sci U S A. 2010.
    • PubMed
    • Abstract available
22. Heldens JG, Glansbeek HL, Hilgers LA, Haenen B, et al.
    • Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
23. Saluja V, Visser MR, Ter Veer W, van Roosmalen ML, et al.
    • Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
24. Stegmann T, Kamphuis T, Meijerhof T, Goud E, et al.
    • Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.
    • Vaccine. 2010.
    • PubMed
    • Abstract available
25. Jiang H, Zhang S, Wang Q, Wang J, et al.
    • Influenza virus genome C4 promoter/origin attenuates its transcription and replication activity by the low polymerase recognition activity.
    • Virology. 2010.
    • PubMed
    • Abstract available
26. Giannecchini S, Clausi V, Di Trani L, Falcone E, et al.
    • Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey.
    • Virology. 2010.
    • PubMed
    • Abstract available
27. De Conto F, Covan S, Arcangeletti MC, Orlandini G, et al.
    • Differential Infectious Entry Of Human Influenza A/Nws/33 Virus (H1n1) In Mammalian Kidney Cells.
    • Virus Res. 2010.
    • PubMed
    • Abstract available
28. Schlaudecker EP, Steinhoff MC.
    • Helping Mothers Prevent Influenza Illness in Their Infants.
    • Pediatrics. 2010.
    • PubMed
29. Yoo BK, Berry A, Kasajima M, Szilagyi PG, et al.
    • Association Between Medicaid Reimbursement and Child Influenza Vaccination Rates.
    • Pediatrics. 2010.
    • PubMed
    • Abstract available

-
------